There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a ...
Theriva™ (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and ...
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The FDA approved a new cancer treatment called Bizengri for adults with certain types of lung and pancreatic cancers. The approval is the first for a treatment designed for cancers with an NRG1 gene ...
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...
In a new survey, radiation oncologists blamed prior authorization delays for multiple harms to patients, including ...
The intra-arterial infusion of gemcitabine by the RenovoCath catheter is currently under investigation and has not been ...